Exploiting cancer stem cells for the identification of mediators involved in brain tumorigenesis

Add to your list(s) Download to your calendar using vCal

• Dr Rossella Galli, Stem Cell Biology Unit, San Raffaele Scientific Institute, Milan, Italy
• Thursday 28 February 2013, 14:30-15:30
• Sackler Lecture Theatre, CIMR, Level 7.

If you have a question about this talk, please contact Dr Ireena Dutta.

Brain tumors are characterized by rapid growth characteristics and extreme invasive behavior, thus being inherently resistant to conventional therapy. Therefore, improvement of treatment options for patients with BTs is imperative. BTs comprise subpopulations of cancer stem cells (CSCs), which are capable to initiate and sustain tumor development. These CSCs phenocopy the tumors of origin, and, as such, are envisioned as a novel and valuable preclinical model to develop new therapeutic approaches for BTs. In particular, gene expression profiles of BT CS Cs, which are characterized by cell line-specific molecular and phenotypic traits, can be exploited in order to identify CSC -restricted molecular mediators, which hold significant advantages in terms of cell-targeting specificity and therapeutic exploitability.

This talk is part of the MRC Cancer Unit Seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• CCC talks for website
• Liam
• MRC Cancer Unit Seminars
• Sackler Lecture Theatre, CIMR, Level 7

Note that ex-directory lists are not shown.